Clarissa received a Master’s Degree in Organic Chemistry at the University of Torino (Italy), and a PhD in Biochemistry at the Medical School in Torino, Italy. During her PhD, she worked at the Joslin Diabetes Center, Harvard Medical School (HMS) Boston, MA, and she later retured to HMS for her post-doc in immuology. In 2001 she received an MBA degree at Simmons College and after that, she joined the Harvard Business School working with Prof. G. Pisand and H. Chesbrough as Research Associate and the MIT Sloan School of Management with Prof. F Murray studying different aspects of the biotech industry and the relationship between biotech and pharma companies.
In 2004 she joined the newly established US office of Abcam, a leading antibody reagent company based in Cambridge UK, becoming its first Marketing Manager for North America. In 2007 she joined the technology transfer at the University of Pennsylvania and then The Fox Chase Cancer Center (FCCC) in Philadelphia. At FCCC, she managed and evaluated a portfolio of technologies and negotiated license agreements, industry-sponsored research agreements, and option agreements from the transfer of technologies from 36 investigators and physicians.
At the end of 2016, after 20 years in the US, she returned to Italy and joined the Bioindustry Park, Ivrea, Torino, as Head of Technology Transfer. Since May 2018, she has been a business strategy consultant for various organizations in Europe and in the US focusing on technology evaluation and valuation, market research, scouting, activities of licensing (in and out), patentability opinions, and identification of investing opportunities. In addition, since 2016 she has been an adjunct Professor at the University of Torino, University of Piemonte Orientale, University of Bologna, and Bologna Business School teaching courses related to entrepreneurship, business plans, innovation, and intellectual property.
Expertise in 1) evaluating and assessing the patentability and commercial potential of invention disclosures, including the identification of corporate partners and negotiation of agreements; 2) identifying strategic collaborators and complementary technological application(s) to in-license; 3) evaluating life science assets, competition, and economic trends and factors affecting their economic value; 4) performing market research and competitive analysis of risks and opportunities of life science assets; 5) drafting marketing material(in english), and planning marketing campaigns to promote the licening of assets.